In this issue:
AVATAR therapy for auditory verbal hallucinations in people with psychosis
Rates and predictors of conversion to schizophrenia or bipolar disorder following substance-induced psychosis
Symptoms and signs before the onset of psychosis
CBD as an adjunctive therapy in schizophrenia
P50 suppression deficits linked to several core features of schizophrenia
Psychological distress among caregivers of individuals with schizophrenia
Antipsychotics and risk of self-harm among schizophrenia patients
Efficacy and safety of antidepressant augmentation of antipsychotics in schizophrenia
Subtherapeutic antipsychotic plasma levels and poor treatment response in schizophrenia
Effects of adjunctive fluvoxamine on metabolic parameters and psychopathology in clozapine-treated patients with schizophrenia
Please login below to download this issue (PDF)